Healio Gastroenterology Current Issue
The following articles appeared in the print edition of Healio Gastroenterology.
Table of Contents
- Therapeutic Drug Monitoring: Empirical Evidence Catches up to Common Sense
-
- FDA Approves Abrilada, Fifth Humira Biosimilar
- FDA Approves Givlaari, First Treatment for Acute Hepatic Porphyria
- FDA Approves Stelara for UC
- Q&A: Navigating Proactive, Reactive TDM in a Private Practice Setting Sushama Gundlapalli, MD, MS
- Diet Changes in Young Adults May Quickly Reduce Depression Symptoms
- Dyssynergic Defecation More Common in OIC
- External Neurostimulation Reduces Pain Scores in Children With IBS
- Few Patients Truly have PPI-Refractory Heartburn Caused by GERD
-
- FMT Decreases Mortality in Severe, Fulminant C. diff
- Low Cancer Suspicion May Mean Longer Wait for Referral
- Non-modifiable Risk Factors Contribute to Early-onset CRC
- ACG President Announces Telehealth Initiative, Lauds Concrete Accomplishments
- Common Medications Linked to Changes in Gut Microbiome
- IBD Prevalence in the UK Significantly Higher than Previous Estimates
- Kratom-related Liver Injuries on the Rise in the US
- Mesalamine Most Commonly Prescribed Crohn’s Disease Treatment Among Older Patients
-
- Novel SGLT1/2 Inhibitor Safe, Tolerable in NASH
- Predictors of Response to Stelara Identified in Crohn’s
- ‘Super Donor’ FMT Effective in IBS
- Terlipressin Demonstrates ‘Major Advance’ in Hepatorenal Syndrome Treatment
- VIDEO: IBD Anti-TNF Use in Early Pregnancy Linked to Preeclampsia Risk
- VIDEO: Oral Budesonide Effective in EoE
- ‘Everyone Needs to See This’: Will Smith Gets a Colonoscopy
- FDA Hears Testimony on Enforcement Discretion of FMT for C. diff
-
- Guest Commentary: FMT, ‘A Life-Saving Therapy,’ Needs Physician, Industry Cooperation Jessica Allegretti, MD, MPH